Skip to main content
Clinical Trials/NCT06930898
NCT06930898CompletedNot Applicable

Improving Breast Health Knowledge Among Women Using a Gamified Metaverse-Based Platform: A Randomized Controlled Trial

University of Malaya2 sites in 2 countries72 target enrollmentStarted: December 1, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
72
Locations
2
Primary Endpoint
Change in Breast Health Knowledge Score from Baseline to 4 Weeks Post-Intervention

Study Overview

Brief Summary

This randomized controlled trial aimed to evaluate the effectiveness of Mammoverse, a gamified metaverse-based educational platform, in improving breast health knowledge among women in China. Participants were randomly assigned to either a gamified or non-gamified version of the platform. Both groups received identical educational content, but only the gamified group experienced interactive game elements such as avatars, progress feedback, and rewards. Knowledge was assessed at baseline, immediately post-intervention, and at 4-week follow-up. The study found that the gamified platform significantly improved knowledge retention and participant engagement compared to the non-gamified version.

This ClinicalTrials.gov registration reflects only the randomized controlled trial (RCT) portion of a broader mixed-methods study that was approved by the University of Malaya Research Ethics Committee (Ref: UM.TNC2/UMREC_3967). The full study protocol includes three methodological approaches, and this registration pertains specifically to the RCT component involving the Mammoverse platform. Other study components are not included in this registration.

Detailed Description

Mammoverse is a 3D metaverse environment designed to promote breast health knowledge through immersive and interactive learning. The gamified version included user avatars, badges, tasks, and personalized feedback to increase motivation and engagement. The study recruited 72 women aged 18 and above, and used a pre-post-follow-up design. Outcome measures were based on an adapted 18-item Breast Health Literacy Questionnaire. The trial was conducted entirely online, with ethics approval from the University of Malaya Research Ethics Committee.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Female participants aged 18 years and above
  • •Able to read and understand Chinese
  • •Access to a digital device and stable internet connection
  • •Willing to provide informed consent

Exclusion Criteria

  • •Cognitive impairment or mental health condition that affects participation
  • •Inability to complete the full intervention and follow-up sessions
  • •Incomplete baseline assessment

Arms & Interventions

Gamified Metaverse Education

Experimental

Participants in this group used the Mammoverse platform with gamified features, including story-based missions, interactive tasks, point-based rewards, achievement badges, and virtual incentives. The educational content was delivered through immersive scenarios to enhance engagement and motivation in learning about breast health.

Intervention: Gamified Mammoverse Platform (Behavioral)

Non-Gamified Metaverse Education

Active Comparator

Participants in this group accessed the Mammoverse platform without any gamified features. The virtual environment delivered identical breast health educational content, but without tasks, points, rewards, badges, or narrative elements.

Intervention: Standard Mammoverse Platform (Behavioral)

Outcomes

Primary Outcomes

Change in Breast Health Knowledge Score from Baseline to 4 Weeks Post-Intervention

Time Frame: Baseline and 4 weeks post-intervention

Assessed using an 18-item adapted Breast Health Literacy Questionnaire. Scores range from 0 to 18, with higher scores indicating greater knowledge. Main comparison is between baseline and 4-week follow-up.

Secondary Outcomes

  • Change in Breast Health Knowledge Score from Baseline to Immediately Post-Intervention(Baseline and immediately post-intervention)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials